CROs

INC Research and inVentiv Health Merge to Form CRO Worth $7.4 Billion
Xtalks
Mon, 05/15/17 - 09:41 am
INC Research
inVentiv
CROs
M&A
Takeda continues global R&D reboot with a new joint venture with PRA
Endpoints
Sat, 04/8/17 - 12:46 pm
Takeda
R&D
CROs
PRA
The development landscape for Non-Alcoholic Steatohepatitis (NASH)
BioPharma Dive
Thu, 11/10/16 - 10:20 am
NASH
drug development
Covance
CROs
Takeda will transfer 300 staffers to CRO in ongoing R&D overhaul
Endpoints
Tue, 09/13/16 - 12:56 pm
Takeda
reorganization
R&D
CROs
InVentiv Health comes on board as Pfizer's fourth CRO
BioPharma Dive
Fri, 07/1/16 - 09:40 am
Pfizer
inVentiv
CROs
R&D
CRO giant inVentiv Health could be in line for a $500M IPO
Fierce Biotech
Sat, 03/5/16 - 09:53 am
CROs
inVentiv
IPOs
CRO giant WuXi is going private in a $3.3B deal
Fierce Biotech
Fri, 08/14/15 - 11:18 am
CROs
WuXi PharmaTech
China
Another Indian CRO in hot water, this time with the WHO
BioPharma Dive
Thu, 07/9/15 - 09:55 am
India
CROs
Quest
Parexel axing 850 jobs in big reorg
BioPharma Dive
Mon, 06/29/15 - 12:15 pm
Parexel
reorganization
layoffs
CROs
Biopharma's R&D budgets stay about flat amid global cuts
Fierce Biotech
Wed, 12/17/14 - 04:23 pm
R&D
CROs
biotech
'Fastest way to biosimilar approval? As the CRO flies,' says industry group
Bio-Pharma Reporter
Wed, 09/17/14 - 04:55 pm
biosimilars
CROs
drug approvals
IPO Filing: PRA Health Sciences
24/7 Wall St
Tue, 09/9/14 - 10:32 am
IPOs
CROs
PRA Health Sciences
CROs rally after AstraZeneca rejects final bid from Pfizer
The Fly on the Wall
Mon, 05/19/14 - 10:30 am
CROs
AstraZeneca
Pfizer
M&A
Charles River Laboratories
Parexel
Covance
US demand for biosimilarity testing growing says specialist CRO
Outsourcing Pharma
Mon, 09/30/13 - 10:36 am
CROs
biosimilars
Payout: More CROs Use Retention And Recruitment Bonuses
Pharmalot
Mon, 08/19/13 - 10:53 am
CROs
Quintiles to Acquire Oncology, Med Device CRO Novella Clinical
Outsourcing Pharma
Thu, 08/15/13 - 10:44 am
Quintiles
Novella Clinical
CROs
devices
M&A
Executives Raise Questions on Clinical Trial Sponsors’ Oversight of CROs
Outsourcing Pharma
Tue, 05/14/13 - 09:21 am
CROs
clinical trials
Quintiles Confirms 'Go Public' Speculation with IPO and Predicts Rosy Future for CROs
Outsourcing Pharma
Tue, 02/19/13 - 10:08 am
IPOs
Quintiles
CROs
Strengthening Moats Mean Improving Returns For CRO Investors
Seeking Alpha
Mon, 12/31/12 - 11:27 am
CROs
Charles River Laboratories
ICON
Buy One, Get One Free at Charles River Laboratories
Yahoo/Morningstar
Fri, 05/11/12 - 11:28 am
Charles River Laboratories
CROs

Pages